Amizon is an antiviral means for system use. Амизон® it is shown for treatment and prevention of flu and acute respiratory viral infections.
Structure
- 1 tablet contains амизона® (an enisamiuma of iodide) 250 mg (0.25 g);
- excipients: lactose, cellulose microcrystalline, povidone, sodium of a kroskarmelloz, calcium stearate;
- cover: OPADRY II Clear 85F19250 (polyethyleneglycol, polysorbate 80, polyvinyl alcohol, talc).
Contraindication
Hypersensitivity to medicaments which contain iodide, molecular iodine or covalently connected iodine and also to other components of drug.
Route of administrationTablet of an enisamium of iodide swallow of
, without chewing in 2 hours prior to food.
Maximum single dose - 1000 mg (1 g), the maximum daily dose - 2000 mg (2 g).
Treatment. The adult enisamium iodide 2 times a day appoint in a dose 500 mg (0.5 g) 3 times or 1000 mg (1 g).
to Children 12 years enisamium iodide are more senior thanappoint in a dose 500 mg (0.5 g) 3 times a day.
to Children aged from 6 up to 12 years are appointed on 125 mg (0.125 g) by 2-3 times a day.
treatment Duration - 7 days.
Prevention. To adults and children 16 years - on 250 mg (0.25 g) within 3-5 days, further - on 250 mg (0.25 g) of 1 times in 2-3 days within 2-3 weeks to children of 6-12 years - on 125 mg (0.125 g) every other day within 2-3 weeks to children aged from 12 up to 16 years - on 250 mg (0.25 g) every other day within 2-3 weeks are more senior.
Reception of an enisamium of iodide leads
Feature of use
to increase in level of iodide in plasma. Secondary increase in level of the circulating iodide starts the mechanism of self-control of function of a thyroid gland at which capture of inorganic iodide thyrocytes is suppressed that promotes prevention of excess formation of thyroid hormones; at the same time the level of thyroid stimulating hormone (Wolf-Chaykov's phenomenon) tranzitorno increases. This effect lasts several days; after the treatment termination the function of a thyroid gland is normalized. Tranzitorny increase in thyroid stimulating hormone within several weeks was in some cases observed. >Pregnant
it is contraindicated to p to use medicament during pregnancy as clinical trials of an enisamium of iodide with participation of pregnant women were not conducted.
Children
not to use Drug in this dosage form to children up to 6 years.
Drivers
Administration of medicament of Amizon® does not affect ability to run motor transport or work with mechanisms.
Overdose
No messages about overdose were received by the medicament Amizon® in clinical trials and at post-registration use.
Specific antidote does not exist.
Side effects
Infection and invasion: folliculitis, nasopharyngitis, rhinitis.
from respiratory organs, a thorax and mediastinum: asthma.
from blood and lymphatic system: lymphadenopathy.
from nervous system: headache, dizziness.
from an organ of sight: the century swelled.
Storage conditionsto Store
in the place protected from light at a temperature not above 25 °C. to Store
out of children's reach.
Characteristics | |
Active ingredients | Amizon |
Amount of active ingredient | 250 mg |
Applicant | Pharmak |
Code of automatic telephone exchange | Enisamiya's J05AX17 iodide |
Interaction with food | Later |
Light sensitivity | Sensitive |
Market status | Original |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | blister |
Producer | PUBLIC JOINT STOCK COMPANY PHARMAK |
Quantity in packing | 40 tablets (2 blisters on 20 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Amizon |
Amizon of the tab. of p/o 0.25g No. 40
- Product Code: 183035
- In Stock
- Ready to ship
-
$33.85